Compounds > perifosine
Page last updated: 2024-09-04

perifosine and ixazomib

perifosine has been researched along with ixazomib in 2 studies

Compound Research Comparison

Studies
(perifosine)		Trials
(perifosine)		Recent Studies (post-2010)
(perifosine)		Studies
(ixazomib)		Trials
(ixazomib)		Recent Studies (post-2010) (ixazomib)
2453114030078289

Protein Interaction Comparison

ProteinTaxonomyperifosine (IC50)ixazomib (IC50)
Proteasome subunit beta type-11Homo sapiens (human)0.015
Proteasome subunit alpha type-7Homo sapiens (human)0.015
Proteasome subunit beta type-1Homo sapiens (human)0.0163
Proteasome subunit alpha type-1Homo sapiens (human)0.015
Proteasome subunit alpha type-2Homo sapiens (human)0.015
Proteasome subunit alpha type-3Homo sapiens (human)0.015
Proteasome subunit alpha type-4Homo sapiens (human)0.015
Proteasome subunit beta type-8Homo sapiens (human)0.015
Proteasome subunit beta type-9Homo sapiens (human)0.015
Proteasome subunit alpha type-5Homo sapiens (human)0.015
Proteasome subunit beta type-4Homo sapiens (human)0.015
Proteasome subunit beta type-6Homo sapiens (human)0.015
Proteasome subunit beta type-5Homo sapiens (human)0.0065
Proteasome subunit beta type-10Homo sapiens (human)0.015
Proteasome subunit beta type-3Homo sapiens (human)0.015
Proteasome subunit beta type-2Homo sapiens (human)1.1817
Proteasome subunit alpha type-6Homo sapiens (human)0.015
ATP-dependent Clp protease proteolytic subunitStaphylococcus aureus subsp. aureus NCTC 83255.3
NACHT, LRR and PYD domains-containing protein 3 Mus musculus (house mouse)0.1995
Proteasome subunit alpha-type 8Homo sapiens (human)0.015
Proteasome subunit beta type-7Homo sapiens (human)0.015

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Cavallo, F; Genadieva-Stavric, S; Palumbo, A1

Reviews

1 review(s) available for perifosine and ixazomib

ArticleYear
New approaches to management of multiple myeloma.
    Current treatment options in oncology, 2014, Volume: 15, Issue:2

    Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Boron Compounds; Boronic Acids; Bortezomib; Depsipeptides; Frail Elderly; Glycine; Humans; Lenalidomide; Middle Aged; Multiple Myeloma; Oligopeptides; Phosphorylcholine; Proteasome Inhibitors; Pyrazines; Quality of Life; Recurrence; Thalidomide; Treatment Outcome

2014

Other Studies

1 other study(ies) available for perifosine and ixazomib

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013